Loading...
Anteris Technologies Global Corp.
AVR•NASDAQ
Healthcare
Medical - Devices
$3.25
$-0.03(-0.91%)
Anteris Technologies Global Corp. (AVR) Financial Performance & Income Statement Overview
Review Anteris Technologies Global Corp.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-1.16%
↓ 1.16%
Operating Income Growth
-62.80%
↓ 62.80%
Net Income Growth
-65.77%
↓ 65.77%
Operating Cash Flow Growth
-76.84%
↓ 76.84%
Operating Margin
-2476.50%
↓ 2476.50%
Gross Margin
53.05%
↑ 53.05%
Net Profit Margin
-3284.56%
↓ 3284.56%
ROE
-292.30%
↓ 292.30%
ROIC
-139.14%
↓ 139.14%
Anteris Technologies Global Corp. (AVR) Income Statement & Financial Overview
Review Anteris Technologies Global Corp.'s (AVR) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $536112.00 | $768981.00 | $631540.00 | $766367.00 |
| Cost of Revenue | $207758.00 | $443546.00 | $312111.00 | $473585.00 |
| Gross Profit | $328354.00 | $325435.00 | $319429.00 | $292782.00 |
| Gross Profit Ratio | $0.61 | $0.42 | $0.51 | $0.38 |
| R&D Expenses | $89.59M | $13.95M | $12.63M | $11.55M |
| SG&A Expenses | $8.53M | $6.98M | $6.16M | $6.52M |
| Operating Expenses | $21.39M | $22.21M | $19.19M | $16.84M |
| Total Costs & Expenses | $21.60M | $22.66M | $19.50M | $17.32M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $11740.00 | $9969.00 | $17445.00 |
| Depreciation & Amortization | $404292.00 | $380589.00 | $376675.00 | $345444.00 |
| EBITDA | -$21.11M | -$21.40M | -$18.43M | -$15.79M |
| EBITDA Ratio | -$39.38 | -$27.83 | -$29.19 | -$20.60 |
| Operating Income | -$21.06M | -$21.89M | -$18.87M | -$16.55M |
| Operating Income Ratio | -$39.29 | -$28.46 | -$29.88 | -$21.60 |
| Other Income/Expenses (Net) | $1.86M | $92253.00 | $53213.00 | $398246.00 |
| Income Before Tax | -$19.20M | -$21.79M | -$18.82M | -$16.15M |
| Income Before Tax Ratio | -$35.82 | -$28.34 | -$29.80 | -$21.08 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$19.38M | -$21.86M | -$18.71M | -$16.35M |
| Net Income Ratio | -$36.14 | -$28.43 | -$29.62 | -$21.33 |
| EPS | -$0.82 | -$0.61 | -$0.52 | -$0.45 |
| Diluted EPS | -$0.82 | -$0.61 | -$0.52 | -$0.45 |
| Weighted Avg Shares Outstanding | $23.58M | $35.94M | $35.94M | $35.94M |
| Weighted Avg Shares Outstanding (Diluted) | $23.58M | $35.94M | $35.94M | $35.94M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan